{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T04:42:16Z","timestamp":1789533736417,"version":"build-2803163510"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003789","name":"Helwan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003789","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Limited data is available regarding the severity and mortality of Mpox in individuals with immunocompromised conditions. Therefore, we performed this meta-analysis to understand the impact of HIV- or non-HIV-associated immunosuppression on the severity of Mpox requiring hospitalization and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A thorough literature search was performed from 2022 up to January 2024. The results were presented as odds ratios (ORs). We only included patients who required hospitalization for severity rather than isolation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 34 studies were included in this analysis. Our analysis did not find a significant difference in the hospitalization risk between HIV-positive individuals and those who were HIV-negative (OR\u2009=\u20091.03; <jats:italic>P<\/jats:italic>\u2009=\u20090.85; 7 studies; CD4 count of fewer than 200 cells\/\u00b5L was less than 0.5% across all studies). Patients with a CD4 count lower than 200 cells\/\u00b5L or an unsuppressed RNA viral load (&gt;\u2009200 copies\/ml) had a significantly higher hospitalization risk (OR\u2009=\u20095.3, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and (OR\u2009=\u20093, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), respectively. Most of the reported deaths were reported in patients with HIV with CD4 counts below 200 cells\/\u00b5L, with some fatal cases occurring in non-HIV immunosuppressed patients, particularly organ transplant recipients. Based on the autopsy findings, Mpox was confirmed in multiple organs, particularly the digestive tract, lung, and testes. Furthermore, some studies documented cases of death that were suspected to be related to hemophagocytic lymphohistiocytosis (HLH) and immune reconstitution inflammatory syndrome (IRIS). Most of the death reports showed concomitant non-Mpox infections at the time of hospitalization and death<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our finding shows that Mpox acts as an opportunistic pathogen in immunocompromised individuals. These individuals should be prioritized for early care and closely monitored for signs of deteriorating clinical conditions. Clinical manifestations and autopsy findings strongly suggest Mpox dissemination to multiple organs, particularly the digestive tract, and lungs. However, the presence of concomitant non-Mpox infections complicates the assessment of the attribution of Mpox to death. Caution should be exercised when interpreting data suggesting poorer outcomes in individuals with non-HIV immunosuppression, as current evidence is scarce and further research is needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12985-024-02392-0","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:08:20Z","timestamp":1717596500000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The impact of immunosuppression on the mortality and hospitalization of Monkeypox: a systematic review and meta-analysis of the 2022 outbreak"],"prefix":"10.1186","volume":"21","author":[{"given":"Ahmed","family":"Azzam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"Khaled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitham","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameer","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira M.","family":"Heniedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan Samy","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghrid S.","family":"El-Mahdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"2392_CR1","unstructured":"World Health Organization. Mpox (monkeypox)- Democratic Republic of the Congo. https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2023-DON493. Accessed 1 Jan 2024."},{"key":"2392_CR2","unstructured":"World Health Organization. Mpox outbreak - PAHO\/WHO | Pan American Health Organization. 2023. https:\/\/www.paho.org\/en\/mpox. Accessed 1 Jan 2024."},{"key":"2392_CR3","unstructured":"World Health Organization. Fourth meeting of the International Health Regulations. (2005) (IHR) Emergency Committee on the Multi-Country Outbreak of monkeypox (mpox). WHO Media Team Email: mediainquiries@who.int. 2023. https:\/\/www.who.int\/news\/item\/11-05-2023-fifth-meeting-of-the-international-health-regulations-(2005)-(ihr)-emergency-committee-on-the-multi-country-outbreak-of-monkeypox-(mpox). Accessed 1 Jan 2024."},{"key":"2392_CR4","unstructured":"Centers for Disease Control and Prevention. About Mpox | Mpox | Poxvirus | CDC. Poxvirus. 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/about\/index.html. Accessed 1 Jan 2024."},{"key":"2392_CR5","first-page":"269","volume":"31","author":"S Antinori","year":"2023","unstructured":"Antinori S, Casalini G, Giacomelli A, Rodriguez-Morales AJ. Update on Mpox: a brief narrative review. Le Infez Med. 2023;31:269.","journal-title":"Le Infez Med"},{"key":"2392_CR6","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/idr14050079","volume":"14","author":"F Antunes","year":"2022","unstructured":"Antunes F, Cordeiro R, Virgolino A, Monkeypox. From a neglected Tropical Disease to a Public Health threat. Infect Dis Rep. 2022;14:772.","journal-title":"Infect Dis Rep"},{"key":"2392_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3390\/vaccines11020246","volume":"11","author":"B Ortiz-Saavedra","year":"2023","unstructured":"Ortiz-Saavedra B, Montes-Madariaga ES, Cabanillas-Ramirez C, Alva N, Ricardo-Mart\u00ednez A, Le\u00f3n-Figueroa DA, et al. Epidemiologic Situation of HIV and Monkeypox Coinfection: a systematic review. Vaccines. 2023;11:246.","journal-title":"Vaccines"},{"key":"2392_CR8","doi-asserted-by":"publisher","first-page":"101710","DOI":"10.1016\/j.eclinm.2022.101710","volume":"54","author":"ME DeWitt","year":"2022","unstructured":"DeWitt ME, Polk C, Williamson J, Shetty AK, Passaretti CL, McNeil CJ, et al. Global monkeypox case hospitalisation rates: a rapid systematic review and meta-analysis. eClinicalMedicine. 2022;54:101710.","journal-title":"eClinicalMedicine"},{"key":"2392_CR9","doi-asserted-by":"publisher","first-page":"404","DOI":"10.15585\/mmwr.mm7215a5","volume":"72","author":"AP Riser","year":"2023","unstructured":"Riser AP, Hanley A, Cima M, Lewis L, Saadeh K, Alarc\u00f3n J, et al. Epidemiologic and clinical features of Mpox-Associated deaths \u2014 United States, May 10, 2022\u2013March 7, 2023. MMWR Morb Mortal Wkly Rep. 2023;72:404\u201310.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2392_CR10","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/S1473-3099(23)00482-6","volume":"24","author":"C Pinnetti","year":"2024","unstructured":"Pinnetti C, Cimini E, Mazzotta V, Matusali G, Vergori A, Mondi A, et al. Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications. Lancet Infect Dis. 2024;24:e127\u201335.","journal-title":"Lancet Infect Dis"},{"key":"2392_CR11","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1056\/NEJMc2214921","volume":"388","author":"J Alarc\u00f3n","year":"2023","unstructured":"Alarc\u00f3n J, Kim M, Terashita D, Davar K, Garrigues JM, Guccione JP, et al. An mpox-related death in the United States. N Engl J Med. 2023;388:1246\u20137.","journal-title":"N Engl J Med"},{"key":"2392_CR12","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1093\/cid\/ciad052","volume":"76","author":"A Govind","year":"2023","unstructured":"Govind A, Lazarte SM, Kitchell E, Chow JY, Estelle CD, Fixsen E, et al. Severe mpox infections in people with uncontrolled human immunodeficiency virus. Clin Infect Dis. 2023;76:1843\u20136.","journal-title":"Clin Infect Dis"},{"key":"2392_CR13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S1473-3099(23)00574-1","volume":"23","author":"AN Duarte-Neto","year":"2023","unstructured":"Duarte-Neto AN, Gon\u00e7alves AM, Eliodoro RH, de Martins A, Claro WD, Valen\u00e7a IM. Main autopsy findings of visceral involvement by fatal mpox in patients with AIDS: necrotising nodular pneumonia, nodular ulcerative colitis, and diffuse vasculopathy. Lancet Infect Dis. 2023;23:1218\u201322.","journal-title":"Lancet Infect Dis"},{"key":"2392_CR14","doi-asserted-by":"crossref","unstructured":"Garneau WM, Jones JL, Dashler GM, Mostafa HH, Judson SD, Kwon N et al. Risk factors for hospitalization and effect of immunosuppression on clinical outcomes among an urban cohort of patients with Mpox. Open Forum Infect Dis. 2023;10.","DOI":"10.1093\/ofid\/ofad533"},{"key":"2392_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(23)00273-8","volume":"401","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Alemany A, Marks M, Lezama Mora JI, Rodr\u00edguez-Aldama JC, Torres Silva MS, et al. Mpox in people with advanced HIV infection: a global case series. Lancet. 2023;401:939\u201349.","journal-title":"Lancet"},{"key":"2392_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.15585\/mmwr.mm7215a5","volume":"72","author":"AP Riser","year":"2023","unstructured":"Riser AP, Hanley A, Cima M, Lewis L, Saadeh K, Alarc\u00f3n J, et al. Epidemiologic and clinical features of Mpox-Associated deaths \u2014 United States, May 10, 2022\u2013March 7, 2023. Morb Mortal Wkly Rep. 2023;72:404.","journal-title":"Morb Mortal Wkly Rep"},{"key":"2392_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-023-00580-6","volume":"20","author":"S Rajme-L\u00f3pez","year":"2023","unstructured":"Rajme-L\u00f3pez S, Corral-Herrera EA, Tello-Mercado AC, Tepo-Ponce KM, P\u00e9rez-Mel\u00e9ndez RE, Rosales-Sotomayor \u00c1, et al. Clinical, molecular, and histological characteristics of severely necrotic and fatal mpox in HIV-infected patients. AIDS Res Ther. 2023;20:1\u20138.","journal-title":"AIDS Res Ther"},{"key":"2392_CR18","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/QAD.0000000000003541","volume":"37","author":"NC Warner","year":"2023","unstructured":"Warner NC, Shishido A, Fulco PP, Sastry S. Immune reconstitution inflammatory syndrome due to monkeypox in two patients with AIDS. AIDS. 2023;37:1187\u20138.","journal-title":"AIDS"},{"key":"2392_CR19","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1177\/09564624231152940","volume":"34","author":"NN Pettit","year":"2023","unstructured":"Pettit NN, Imam S, Sherer R, Hazra A. Treatment options for severe or refractory mpox virus infection in patients with advanced HIV. Int J STD AIDS. 2023;34:366\u201373.","journal-title":"Int J STD AIDS"},{"key":"2392_CR20","unstructured":"PRISMA. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). http:\/\/www.prisma-statement.org\/. Accessed 3 Jan 2024."},{"key":"2392_CR21","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2021. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. Accessed 3 Jan 2024."},{"key":"2392_CR22","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/hiv.13378","volume":"24","author":"C Hoffmann","year":"2023","unstructured":"Hoffmann C, Jessen H, Wyen C, Grunwald S, Noe S, Teichmann J, et al. Clinical characteristics of monkeypox virus infections among men with and without HIV: a large outbreak cohort in Germany. HIV Med. 2023;24:389\u201397.","journal-title":"HIV Med"},{"key":"2392_CR23","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/microorganisms11112701","volume":"11","author":"R Mart\u00edn-Iguacel","year":"2023","unstructured":"Mart\u00edn-Iguacel R, Pericas C, Bruguera A, Rosell G, Mart\u00ednez E, D\u00edaz Y, et al. Mpox: clinical outcomes and impact of vaccination in people with and without HIV: A Population-wide study. Microorganisms. 2023;11:2701.","journal-title":"Microorganisms"},{"key":"2392_CR24","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(22)00651-X","volume":"23","author":"KM Angelo","year":"2023","unstructured":"Angelo KM, Smith T, Camprub\u00ed-Ferrer D, Balerdi-Sarasola L, D\u00edaz Men\u00e9ndez M, Servera-Negre G, et al. Epidemiological and clinical characteristics of patients with monkeypox in the GeoSentinel Network: a cross-sectional study. Lancet Infect Dis. 2023;23:196\u2013206.","journal-title":"Lancet Infect Dis"},{"key":"2392_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003748","author":"MST Silva","year":"2023","unstructured":"Silva MST, Coutinho C, Torres TS, Peixoto EM, Bastos MO, Mesquita MB, et al. Mpox severity and associated hospitalizations among people living with HIV and related immunosuppression in Brazil. AIDS. 2023. https:\/\/doi.org\/10.1097\/QAD.0000000000003748.","journal-title":"AIDS"},{"key":"2392_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/CID\/CIAD482","author":"DC Philpott","year":"2023","unstructured":"Philpott DC, Bonacci RA, Weidle PJ, Curran KG, Brooks JT, Khalil G, et al. Low CD4 count or being out of Care increases the risk for Mpox Hospitalization among people with Human Immunodeficiency Virus and Mpox. Clin Infect Dis. 2023. https:\/\/doi.org\/10.1093\/CID\/CIAD482.","journal-title":"Clin Infect Dis"},{"key":"2392_CR27","doi-asserted-by":"publisher","first-page":"810","DOI":"10.3390\/idr14060083","volume":"14","author":"J Caria","year":"2022","unstructured":"Caria J, Pinto R, Leal E, Almeida V, Crist\u00f3v\u00e3o G, Gon\u00e7alves AC, et al. Clinical and epidemiological features of hospitalized and ambulatory patients with human monkeypox infection: a retrospective observational study in Portugal. Infect Dis Rep 2022. 2022;14:810\u201323.","journal-title":"Infect Dis Rep 2022"},{"key":"2392_CR28","doi-asserted-by":"crossref","unstructured":"Est\u00e9vez S, Vara M, Gamo M, Manzano S, Troya J, Botezat E et al. Epidemiological and Clinical Characteristics of Patients Admitted to a Secondary Hospital with Suspected MPOX Virus Infection: Is HIV Playing a Role? J Clin Med. 2023, Vol 12, Page 4124. 2023;12:4124.","DOI":"10.3390\/jcm12124124"},{"key":"2392_CR29","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/QAD.0000000000003449","volume":"37","author":"DB Chastain","year":"2023","unstructured":"Chastain DB, Motoa G, Ortiz-Mart\u00ednez Y, Gharamti A, Henao-Mart\u00ednez AF. Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort. AIDS. 2023;37:611\u20136.","journal-title":"AIDS"},{"key":"2392_CR30","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3201\/eid2906.230021","volume":"29","author":"HK Brosnan","year":"2023","unstructured":"Brosnan HK, Yeh KW, Jones PS, Gokhale S, Regos-Stewart D, Tran H, et al. Epidemiologic Characteristics of Mpox among people experiencing homelessness, Los Angeles County, California, USA, 2022 - 29, number 6\u2014June 2023 - emerging infectious diseases journal - CDC. Emerg Infect Dis. 2023;29:1109\u201316.","journal-title":"Emerg Infect Dis"},{"key":"2392_CR31","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3201\/eid2906.230059","volume":"29","author":"E Filippov","year":"2023","unstructured":"Filippov E, Duhan S, Lehman L, Keisham B, Sethi V. Treatment failure in patient with severe mpox and untreated HIV, Maryland, USA - 29, number 6\u2014June 2023 - emerging infectious diseases journal - CDC. Emerg Infect Dis. 2023;29:1262\u20135.","journal-title":"Emerg Infect Dis"},{"key":"2392_CR32","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1097\/QAD.0000000000003623","volume":"37","author":"S Triana-Gonz\u00e1lez","year":"2023","unstructured":"Triana-Gonz\u00e1lez S, Rom\u00e1n-L\u00f3pez C, Mauss S, Cano-D\u00edaz AL, Mata-Mar\u00edn JA, P\u00e9rez-Barrag\u00e1n E, et al. Risk factors for mortality and clinical presentation of monkeypox. AIDS. 2023;37:1979\u201385.","journal-title":"AIDS"},{"key":"2392_CR33","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Moreno CA, Alzate-\u00c1ngel JC, De La Hoz-Siegler IH, Bare\u00f1o A, Mantilla M, Sussman O et al. Clinical and epidemiological characteristics of mpox: a descriptive cases series in Colombia. Travel Med Infect Dis. 2023;53.","DOI":"10.1016\/j.tmaid.2023.102594"},{"key":"2392_CR34","first-page":"100392","volume":"17","author":"I N\u00fa\u00f1ez","year":"2023","unstructured":"N\u00fa\u00f1ez I, Garc\u00eda-Grimshaw M, Ceballos-Liceaga SE, Toledo-Salinas C, Carbajal-Sandoval G, Sosa-Laso L, et al. Epidemiological and clinical characteristics of patients with human monkeypox infection in Mexico: a nationwide observational study. Lancet Reg Heal - Am. 2023;17:100392.","journal-title":"Lancet Reg Heal - Am"},{"key":"2392_CR35","doi-asserted-by":"publisher","first-page":"e0228","DOI":"10.1590\/0037-8682-0228-2023","volume":"56","author":"LABG Farias","year":"2023","unstructured":"Farias LABG, de Holanda PEL, da Silva ADT, Cavalcante KF, Juc\u00e1 MCP, Neto LVP, et al. Severe mpox in patients with advanced AIDS: long-term disease and fatal outcome. Rev Soc Bras Med Trop. 2023;56:e0228\u20132023.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2392_CR36","doi-asserted-by":"publisher","first-page":"e0392","DOI":"10.1590\/0037-8682-0392-2022","volume":"55","author":"YR Menezes","year":"2022","unstructured":"Menezes YR, de Miranda AB. Severe disseminated clinical presentation of monkeypox virus infection in an immunosuppressed patient: first death report in Brazil. Rev Soc Bras Med Trop. 2022;55:e0392\u20132022.","journal-title":"Rev Soc Bras Med Trop"},{"key":"2392_CR37","doi-asserted-by":"publisher","first-page":"e190","DOI":"10.1016\/S1473-3099(22)00869-6","volume":"23","author":"S Carrubba","year":"2023","unstructured":"Carrubba S, Geevarghese A, Solli E, Guttha S, Sims J, Sperber L, et al. Novel severe oculocutaneous manifestations of human monkeypox virus infection and their historical analogues. Lancet Infect Dis. 2023;23:e190\u20137.","journal-title":"Lancet Infect Dis"},{"key":"2392_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/idr15020018","volume":"15","author":"J Caria","year":"2023","unstructured":"Caria J, Vara-Luiz F, Maia I, Joosten A, Val-Flores L, Pinheiro H, et al. Fatal Case of Progressive Mpox in a patient with AIDS\u2014Viral enteropathy and malabsorption demanding the use of full parenteral ARV and endovenous cidofovir. Infect Dis Rep 2023. 2023;15:171\u20139.","journal-title":"Infect Dis Rep 2023"},{"key":"2392_CR39","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.ajt.2023.07.017","volume":"23","author":"R Fuller","year":"2023","unstructured":"Fuller R, Cederroth T, Patel G, Reidy J, Pati\u00f1o LH, Ram\u00edrez JD, et al. First case of rapidly fatal mpox from secondary (household) transmission in a kidney transplant recipient. Am J Transpl. 2023;23:1995\u20139.","journal-title":"Am J Transpl"},{"key":"2392_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIAD505","author":"B Aldred","year":"2023","unstructured":"Aldred B, Scott JY, Aldredge A, Gromer DJ, Anderson AM, Cartwright EJ, et al. Associations between HIV and severe mpox in an Atlanta Cohort. J Infect Dis. 2023. https:\/\/doi.org\/10.1093\/INFDIS\/JIAD505.","journal-title":"J Infect Dis"},{"key":"2392_CR41","doi-asserted-by":"publisher","first-page":"A1325","DOI":"10.1016\/j.chest.2023.07.930","volume":"164","author":"G SUN","year":"2023","unstructured":"SUN G, TEJA KOLLI S, ASUZU C, NIHALANI S, ZHU M, STOECKEL JE, et al. The First Human to have necrotizing Pneumonia secondary to monkeypox infection. Chest. 2023;164:A1325\u20136.","journal-title":"Chest"},{"key":"2392_CR42","doi-asserted-by":"publisher","first-page":"A2068","DOI":"10.1016\/j.chest.2023.07.1413","volume":"164","author":"R MOHAMMED","year":"2023","unstructured":"MOHAMMED R, ENG A, MILEKIC B. Severe disseminated monkeypox in an immunosuppressed non-vaccinated patient: First Death Report in New York City. Chest. 2023;164:A2068\u20139.","journal-title":"Chest"},{"key":"2392_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/INFDIS\/JIAD574","author":"JM Ritter","year":"2024","unstructured":"Ritter JM, Martines RB, Bhatnagar J, Rao AK, Villalba JA, Silva-Flannery L, et al. Pathology and Monkeypox virus localization in tissues from immunocompromised patients with severe or fatal mpox. J Infect Dis. 2024. https:\/\/doi.org\/10.1093\/INFDIS\/JIAD574.","journal-title":"J Infect Dis"},{"key":"2392_CR44","doi-asserted-by":"publisher","first-page":"e1012","DOI":"10.1016\/S2214-109X(23)00198-5","volume":"11","author":"H Laurenson-Schafer","year":"2023","unstructured":"Laurenson-Schafer H, Sklenovsk\u00e1 N, Hoxha A, Kerr SM, Ndumbi P, Fitzner J, et al. Description of the first global outbreak of mpox: an analysis of global surveillance data. Lancet Glob Heal. 2023;11:e1012\u201323.","journal-title":"Lancet Glob Heal"},{"key":"2392_CR45","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.ajt.2023.07.016","volume":"23","author":"E Higgins","year":"2023","unstructured":"Higgins E, Ranganath N, Mehkri O, Majeed A, Walker J, Spivack S, et al. Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: a multicenter case series and literature review. Am J Transpl. 2023;23:1972\u20139.","journal-title":"Am J Transpl"},{"key":"2392_CR46","doi-asserted-by":"crossref","unstructured":"Pilkington V, Quinn K, Campbell L, Payne L, Brady M, Post FA. Clinical Presentation of Mpox in People With and Without HIV in the United Kingdom During the 2022 Global Outbreak. https:\/\/home.liebertpub.com\/aid. 2023;39:581\u20136.","DOI":"10.1089\/aid.2023.0014"},{"key":"2392_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s10238-022-00840-1","volume":"23","author":"X Han","year":"2023","unstructured":"Han X, Hou H, Xu J, Ren J, Li S, Wang Y, et al. Significant association between HIV infection and increased risk of COVID-19 mortality: a meta-analysis based on adjusted effect estimates. Clin Exp Med. 2023;23:689\u2013700.","journal-title":"Clin Exp Med"},{"key":"2392_CR48","doi-asserted-by":"publisher","first-page":"864838","DOI":"10.3389\/fimmu.2022.864838","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Xie Y, Hu S, Ai W, Tao Y, Tang H, et al. Systematic review and Meta-analyses of the Interaction between HIV infection and COVID-19: two years\u2019 evidence Summary. Front Immunol. 2022;13:864838.","journal-title":"Front Immunol"},{"key":"2392_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-85359-3","volume":"11","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11:1\u201312.","journal-title":"Sci Rep"},{"key":"2392_CR50","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jiph.2022.05.006","volume":"15","author":"T Dzinamarira","year":"2022","unstructured":"Dzinamarira T, Murewanhema G, Chitungo I, Ngara B, Nkambule SJ, Madziva R, et al. Risk of mortality in HIV-infected COVID-19 patients: a systematic review and meta-analysis. J Infect Public Health. 2022;15:654\u201361.","journal-title":"J Infect Public Health"},{"key":"2392_CR51","unstructured":"Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of High-Consequence Pathogens and Pathology (DHCPP). Clinical Considerations for Treatment and Prophylaxis of Mpox Infection in People Who are Immunocompromised. 2023. https:\/\/www.cdc.gov\/poxvirus\/mpox\/clinicians\/people-with-HIV.html#anchor_1670628054467. Accessed 6 Jan 2024."},{"key":"2392_CR52","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/cid\/cit456","volume":"57","author":"DR Snydman","year":"2013","unstructured":"Snydman DR, Waggoner JJ, Soda EA, Deresinski S. Rare and emerging viral infections in transplant recipients. Clin Infect Dis. 2013;57:1182\u20138.","journal-title":"Clin Infect Dis"},{"key":"2392_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-016-3534-y","volume":"32","author":"P Gazzani","year":"2017","unstructured":"Gazzani P, Gach JE, Colmenero I, Martin J, Morton H, Brown K, et al. Fatal disseminated cowpox virus infection in an adolescent renal transplant recipient. Pediatr Nephrol. 2017;32:533\u20136.","journal-title":"Pediatr Nephrol"},{"key":"2392_CR54","doi-asserted-by":"publisher","first-page":"1132250","DOI":"10.3389\/fimmu.2023.1132250","volume":"14","author":"L Niu","year":"2023","unstructured":"Niu L, Liang D, Ling Q, Zhang J, Li Z, Zhang D, et al. Insights into monkeypox pathophysiology, global prevalence, clinical manifestation and treatments. Front Immunol. 2023;14:1132250.","journal-title":"Front Immunol"},{"key":"2392_CR55","doi-asserted-by":"publisher","first-page":"e6592","DOI":"10.1371\/journal.pone.0006592","volume":"4","author":"JE Osorio","year":"2009","unstructured":"Osorio JE, Iams KP, Meteyer CU, Rocke TE. Comparison of Monkeypox Viruses Pathogenesis in mice by in vivo imaging. PLoS ONE. 2009;4:e6592.","journal-title":"PLoS ONE"},{"key":"2392_CR56","doi-asserted-by":"publisher","first-page":"866","DOI":"10.4103\/0971-5916.92632","volume":"134","author":"SK Sharma","year":"2011","unstructured":"Sharma SK, Soneja M. HIV & immune reconstitution inflammatory syndrome (IRIS). Indian J Med Res. 2011;134:866.","journal-title":"Indian J Med Res"},{"key":"2392_CR57","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1182\/blood-2004-08-3296","volume":"105","author":"E Ishii","year":"2005","unstructured":"Ishii E, Ueda I, Shirakawa R, Yamamoto K, Horiuchi H, Ohga S, et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte\/natural killer cell functions. Blood. 2005;105:3442\u20138.","journal-title":"Blood"},{"key":"2392_CR58","doi-asserted-by":"crossref","unstructured":"Zhang Hqi, Yang SW, Fu YC, Chen MC, Yang CH, Yang MH et al. Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis. Immunol Res 2022 705. 2022;70:566\u201377.","DOI":"10.1007\/s12026-022-09285-w"},{"key":"2392_CR59","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/S0140-6736(23)01896-2","volume":"402","author":"O Mitj\u00e0","year":"2023","unstructured":"Mitj\u00e0 O, Paredes R, Cabtree B, Orkin C. Classifying necrotising mpox as an AIDS-defining condition. Lancet. 2023;402:1751\u20132.","journal-title":"Lancet"},{"key":"2392_CR60","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/S0140-6736(23)01898-6","volume":"402","author":"I N\u00fa\u00f1ez","year":"2023","unstructured":"N\u00fa\u00f1ez I, Vald\u00e9s-Ferrer SI. Classifying necrotising mpox as an AIDS-defining condition \u2013 authors\u2019 reply. Lancet. 2023;402:1752.","journal-title":"Lancet"},{"key":"2392_CR61","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/S0140-6736(23)00333-1","volume":"401","author":"I N\u00fa\u00f1ez","year":"2023","unstructured":"N\u00fa\u00f1ez I, Vald\u00e9s-Ferrer SI. Fulminant mpox as an AIDS-defining condition: useful or stigmatising? Lancet. 2023;401:881\u20134.","journal-title":"Lancet"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02392-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-024-02392-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-024-02392-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:06:24Z","timestamp":1717599984000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-024-02392-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2392"],"URL":"https:\/\/doi.org\/10.1186\/s12985-024-02392-0","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"9 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"130"}}